Investor Relations
Key Figures
| IFRS (in EURm except otherwise stated) | 2018 | 2017 |
| Revenues | 3,781.1 | 2,971.4 |
| Adjusted EBITDA | 719.8 | 556.7 |
| Reported EBITDA | 651.4 | 513.2 |
| Adjusted Basic EPS (EUR) | 20.11 | 17.49 |
| Net Operating Cash Flow | 543.9 | 405.1 |
Outstanding shares:
17,781,079 (at 30.04.2019)
Dividend
The AGM of 26 April 2018 approved the payment of a dividend of EUR 2.40 per share for the year 2017 compared to EUR 2.00 for the previous year.
Financial News
- 26.04.2019Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m
- 15.04.2019Eurofins announces a buy-back of a minority stake owned by biologists in Eurofins Laboratoire des Pyramides (France)
- 27.03.2019NTD Eurofins Attains New York State Department of Health (NYSDOH) Approval for the newest option to its MaternalFetalScreenSM | T1 test – Y chromosome assessment
- 05.03.2019Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m (+27% yoy) and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives
- 05.12.2018Eurofins expands its footprint in advanced materials sciences through an outsourcing agreement with Signify (formerly: Philips Lighting) in the Netherlands
Annual Reports
Next Publication: HY 2019 Results Publication, 29 August 2019
Order a hard copy of the 2017 Annual Report
Eurofins' 20-year IPO value creation study by Marten & Co.
Research Paper by Prof. Brooks
OBSAAR prospectus in French only
